Exploring Mdsr 2024 Classification Prognostication Session
If you are looking for information about Mdsr 2024 Classification Prognostication Session, you have come to the right place.
- Overview of the treatment for HR-MDS - Pierre Fenaux New drugs including Abs and BCL2-inhibitor for HRMDS - Guillermo ...
- A roundtable discussion, moderated by Amer Zeidan, MBBS, MHS, of Yale University, focused on the latest updates in the care of ...
- Dysplasia, and low risk situations (ICUS, CCUS, CHIP) - John Bennett.
- CMML/clinical progress - Raphael Itzykson CMML molecular pathogenesis - Eric Solary.
- Genetic and clinical diagnosis based on bone marrow cell morphology - Oscar Brück Use AI for diagnosis, etc. - Torsten ...
In-Depth Information on Mdsr 2024 Classification Prognostication Session
Molecular Review of the two (and more) DDX41 - Carmelo Gurnari (USA) GATA2/SAMD9 genetic predisposition - Marcin Wlodarski JMML etc. - Hideki Muramatsu. Overview of the treatment for LR-MDS - Eva Hellström-Lindberg SF3B1 - Michaela Fontenay.
Moderator: Moshe Mittelman Panel: Rafael Bejar, Amer Zeidan, Yasushi Miyazaki.
We hope this detailed breakdown of Mdsr 2024 Classification Prognostication Session was helpful.
